Issue 2, 2017

Aryl-alkyl-lysines: small molecular membrane-active antiplasmodial agents

Abstract

Due to emerging resistance there is a steady need for new antimalarial drugs. Here, we report a new class of water soluble, non-toxic compounds, aryl-alkyl-lysines, with promising activity against the ring stage of Plasmodium falciparum. The optimal compound perturbed the plasma membrane potential and the digestive vacuole of parasites. In the murine model of malaria (Plasmodium berghei ANKA) the compound was able to increase the survival of mice by at least 5 days by an intra-peritoneal route. Further, the compounds showed no apparent toxicity to mice at the concentration tested.

Graphical abstract: Aryl-alkyl-lysines: small molecular membrane-active antiplasmodial agents

Supplementary files

Article information

Article type
Research Article
Submitted
23 Oct 2016
Accepted
06 Dec 2016
First published
16 Dec 2016

Med. Chem. Commun., 2017,8, 434-439

Aryl-alkyl-lysines: small molecular membrane-active antiplasmodial agents

C. Ghosh, S. Chaubey, U. Tatu and J. Haldar, Med. Chem. Commun., 2017, 8, 434 DOI: 10.1039/C6MD00589F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements